Skip to main content

Par Pharmaceutical Companies, Inc. (NYSE:PRX) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By TPG

  • If you purchased shares of Par Pharmaceutical Companies, Inc. (NYSE:PRX) prior to July 13, 2012, and currently hold any of those NYSE:PRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

July 16, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Par Pharmaceutical Companies, Inc. (NYSE:PRX) shares was announced concerning whether the offer to acquire Par Pharmaceutical Companies, Inc. and the takeover process are unfair to investors in NYSE:PRX shares. The investigation by a law firm concerns whether certain officers and directors of Par Pha...



You must register (for free) or login to view the entire investigation.